Revogliform 2/0.2 Tablet SR
Marketer
Dr.Revmax Healthcare
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.2mg)
Overview Revogliform 2/0.2 Tablet SR
Combiflex 2/0.2 Extended-Release Tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by managing blood glucose levels. Always take Combiflex 2/0.2 ER Tablets with food, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as discontinuation without medical supervision can elevate glucose levels, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication is one component of a comprehensive diabetes management plan that includes a healthy diet, regular exercise, and weight management as directed by your doctor. Lifestyle choices are integral to diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by symptoms like sweating, dizziness, headache, and tremors. Learn to recognize and treat these symptoms. Maintain regular mealtimes and always carry a readily available fast-acting sugar source, such as glucose tablets or fruit juice. Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Additional possible side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, cephalgia, edema, blurred vision, bone fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Inform your physician of any history of heart conditions before initiating treatment, as it may not be appropriate. Pregnant or lactating individuals should seek medical advice prior to use. Regular blood glucose monitoring is essential, and your doctor may order blood tests to assess blood cell counts and liver function.
Uses of Revogliform 2/0.2 Tablet SR
Managing type 2 diabetes
Major Benefits of Revogliform 2/0.2 Tablet SR:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Revogliform 2/0.2 Tablet SR whole; do not break, crush, or chew it. Administer on an empty stomach.
Common Side effects of Revogliform 2/0.2 Tablet SR:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Revogliform 2/0.2 Tablet SR:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Revogliform 2/0.2 Tablet SR on an empty stomach.
How Revogliform 2/0.2 Tablet SR works:
Extended-release Revogliform tablets (2mg/0.2mg) contain a triple-drug formulation for diabetes management.
SAFETY ADVICE
AlcoholUNSAFE
Combining Revogliform 2/0.2 Tablet SR with alcohol is strongly discouraged due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
Using Revogliform 2/0.2 Tablet SR during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the potential advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Prolonged-release Revogliform 2/0.2 mg tablets are likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyUNSAFE
Patients with kidney disease should likely not take Revogliform 2/0.2 Tablet SR, and its use should be avoided. Medical advice is recommended. The use of Revogliform 2/0.2 Tablet SR is contraindicated in individuals with severely impaired kidney function.
LiverCAUTION
Patients with liver impairment should use Revogliform 2/0.2 Tablet SR cautiously, potentially requiring dosage modification. Consult your physician. A reduced initial dose is typically recommended for those with mild to moderate liver disease; however, its use is contraindicated in patients with severe hepatic dysfunction.
What if you forget to take Revogliform 2/0.2 Tablet SR :
Should you forget a Revogliform 2/0.2 Tablet SR dose, take it immediately. However, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Revogliform 2/0.2 Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently